Comparative Toxicity and Effectiveness of Trastuzumab-Based Chemotherapy Regimens in Older Women With Early-Stage Breast Cancer

PURPOSE: The combination of chemotherapy and trastuzumab is the standard of care for adjuvant treatment of human epidermal growth factor receptor 2–positive breast cancer. Two regimens have been widely adopted in the United States: doxorubicin, cyclophosphamide, paclitaxel, and trastuzumab (ACTH) an...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Clin Oncol
Main Authors: Reeder-Hayes, Katherine E., Meyer, Anne Marie, Hinton, Sharon Peacock, Meng, Ke, Carey, Lisa A., Dusetzina, Stacie B.
Format: Artigo
Jezik:Inglês
Izdano: American Society of Clinical Oncology 2017
Teme:
ORIGINAL REPORTS
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5652869/
https://ncbi.nlm.nih.gov/pubmed/28727517
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2016.71.4345
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki